Windtree Therapeutics Inc (WINT)
4.14
-0.22
(-5.15%)
USD |
NASDAQ |
May 10, 16:00
4.14
0.00 (0.00%)
After-Hours: 17:11
Windtree Therapeutics Enterprise Value: -1.859M for May 9, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 09, 2024 | -1.859M |
| May 08, 2024 | -1.652M |
| May 07, 2024 | -1.841M |
| May 06, 2024 | -1.599M |
| May 03, 2024 | -1.566M |
| May 02, 2024 | -1.877M |
| May 01, 2024 | -1.795M |
| April 30, 2024 | -1.502M |
| April 29, 2024 | -1.382M |
| April 26, 2024 | -1.418M |
| April 25, 2024 | -1.499M |
| April 24, 2024 | -1.456M |
| April 23, 2024 | -1.186M |
| April 22, 2024 | -1.305M |
| April 19, 2024 | -0.947M |
| April 18, 2024 | -0.9654M |
| April 17, 2024 | -0.4006M |
| April 16, 2024 | -0.2151M |
| April 15, 2024 | -0.1894M |
| April 12, 2024 | -0.0911M |
| April 11, 2024 | -0.6054M |
| April 10, 2024 | -0.5962M |
| April 09, 2024 | -0.6789M |
| April 08, 2024 | -0.3207M |
| April 05, 2024 | -0.1949M |
| Date | Value |
|---|---|
| April 04, 2024 | -0.5632M |
| April 03, 2024 | -0.5962M |
| April 02, 2024 | -0.7064M |
| April 01, 2024 | -0.7255M |
| March 28, 2024 | -0.8356M |
| March 27, 2024 | -0.708M |
| March 26, 2024 | -0.8384M |
| March 25, 2024 | -0.7815M |
| March 22, 2024 | -0.7806M |
| March 21, 2024 | -0.8265M |
| March 20, 2024 | -0.8301M |
| March 19, 2024 | -0.8724M |
| March 18, 2024 | -0.955M |
| March 15, 2024 | -0.9642M |
| March 14, 2024 | -0.8944M |
| March 13, 2024 | -0.6704M |
| March 12, 2024 | -0.4913M |
| March 11, 2024 | -0.3766M |
| March 08, 2024 | -0.5066M |
| March 07, 2024 | -0.5822M |
| March 06, 2024 | -0.4316M |
| March 05, 2024 | -0.5051M |
| March 04, 2024 | -0.4133M |
| March 01, 2024 | -0.5097M |
| February 29, 2024 | -0.7806M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-6.288M
Minimum
Sep 25 2023
167.50M
Maximum
Dec 06 2019
46.02M
Average
19.72M
Median
Enterprise Value Benchmarks
| Lexicon Pharmaceuticals Inc | 208.46M |
| AIM ImmunoTech Inc | 9.406M |
| Perspective Therapeutics Inc | 1.049B |
| Protalix BioTherapeutics Inc | 67.01M |
| Armata Pharmaceuticals Inc | 186.62M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -5.154M |
| Total Expenses (Quarterly) | 4.959M |
| EPS Diluted (Quarterly) | -13.32 |
| Earnings Yield | -3.48K% |
| Normalized Earnings Yield | -141349.8 |